Posted on 3月 17, 20233/17/23
Successfully Navigating Self-Commercialisation in Europe
Posted on 3月 15, 20233/15/23
Successful Launches in Europe: Complex, but Not Complicated?
Posted on 3月 13, 20233/13/23
Accelerated Approval Pathways: Manufacturers Left to Grapple With Risk Versus Reward
Posted on 1月 30, 20231/30/23
Bending the “Commercialization Curve” in Large Pharma
Posted on 1月 13, 20231/13/23
Trade & Channel Strategies: Partnership Pavilion Panel
Posted on 12月 22, 202212/22/22
Pivot Pros: How EVERSANA Course Corrected When the Market Changed
Posted on 11月 9, 202211/9/22
EVERSANA™ COMPLETE Commercialization – Executing on 4 Key Performance Indicators
Posted on 10月 24, 202210/24/22
David and Goliath: How Can First-Time Launchers Avoid Failure and Beat Big Pharma Launches
Posted on 8月 2, 20228/2/22
How to Ensure Speed and Efficiency When Launching in Canada
Posted on 3月 11, 20223/11/22